Home NDC 63539-122 Duavee
Product NDC 63539-122
11-digit product format 635390122
Labeler code 63539
Product ID 63539-122_7e3443ae-8aa6-473c-923c-aac11d3b30e9
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name conjugated estrogens/bazedoxifene
Dosage form TABLET, FILM COATED
Route ORAL
Labeler U.S. Pharmaceuticals
Application NDA022247
Marketing category NDA
Marketing start 2013-11-15
Marketing end 2026-12-31
Substance ESTROGENS, CONJUGATED; BAZEDOXIFENE ACETATE
Active strength .45; 20 mg/1; mg/1
Pharmacologic classes Estrogen Agonist/Antagonist [EPC], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS], Selective Estrogen Receptor Modulators [MoA]
NDC exclude flag No
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022247-001 DUAVEE BAZEDOXIFENE ACETATE; ESTROGENS, CONJUGATED EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03
Orange Book patents# Current patent rows page 1 of 1 · 2 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N022247-001 7683051 2027-03-10 U-594 Drug substance, Drug product 2013-10-31 N022247-001 7683051 2027-03-10 U-904 Drug substance, Drug product 2013-10-31
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 45 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 c2088c7a36db…2026-09-14 22:38:34 2026-08 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 84e616aacf4f…2026-08-18 06:07:40 2026-07 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N022247-001 DUAVEE EQ 20MG BASE;0.45MG TABLET / ORAL RLD, RS 2013-10-03 3bdfa0b2c4d7…
Observed Orange Book patent history# Patent history page 1 of 5 · 168 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-11-14 07:37:17 2026-10 N022247-001 7683051 2027-03-10 U-594 Drug substance, Drug product 2013-10-31 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N022247-001 7683051 2027-03-10 U-904 Drug substance, Drug product 2013-10-31 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N022247-001 7683051 2027-03-10 U-594 Drug substance, Drug product 2013-10-31 c2088c7a36db…2026-10-15 13:18:30 2026-09 N022247-001 7683051 2027-03-10 U-904 Drug substance, Drug product 2013-10-31 c2088c7a36db…2026-09-14 22:38:34 2026-08 N022247-001 7683051 2027-03-10 U-594 Drug substance, Drug product 2013-10-31 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022247-001 7683051 2027-03-10 U-904 Drug substance, Drug product 2013-10-31 84e616aacf4f…2026-08-18 06:07:40 2026-07 N022247-001 7683051 2027-03-10 U-594 Drug substance, Drug product 2013-10-31 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022247-001 7683051 2027-03-10 U-904 Drug substance, Drug product 2013-10-31 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022247-001 7683051 2027-03-10 U-594 Drug substance, Drug product 2013-10-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022247-001 7683051 2027-03-10 U-904 Drug substance, Drug product 2013-10-31 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022247-001 7683051 2027-03-10 U-594 Drug substance, Drug product 2013-10-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022247-001 7683051 2027-03-10 U-904 Drug substance, Drug product 2013-10-31 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022247-001 7683051 2027-03-10 U-594 Drug substance, Drug product 2013-10-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022247-001 7683051 2027-03-10 U-904 Drug substance, Drug product 2013-10-31 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022247-001 7683051 2027-03-10 U-594 Drug substance, Drug product 2013-10-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022247-001 7683051 2027-03-10 U-904 Drug substance, Drug product 2013-10-31 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022247-001 7683051 2027-03-10 U-594 Drug substance, Drug product 2013-10-31 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022247-001 7683051 2027-03-10 U-904 Drug substance, Drug product 2013-10-31 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022247-001 6479535 2024-05-06 U-594 Drug product 2013-10-31 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022247-001 6479535 2024-05-06 U-904 Drug product 2013-10-31 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022247-001 7683051 2027-03-10 U-594 Drug substance, Drug product 2013-10-31 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022247-001 7683051 2027-03-10 U-904 Drug substance, Drug product 2013-10-31 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022247-001 6479535 2024-05-06 U-594 Drug product 2013-10-31 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022247-001 6479535 2024-05-06 U-904 Drug product 2013-10-31 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022247-001 7683051 2027-03-10 U-594 Drug substance, Drug product 2013-10-31 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022247-001 7683051 2027-03-10 U-904 Drug substance, Drug product 2013-10-31 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022247-001 6479535 2024-05-06 U-594 Drug product 2013-10-31 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022247-001 6479535 2024-05-06 U-904 Drug product 2013-10-31 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022247-001 7683051 2027-03-10 U-594 Drug substance, Drug product 2013-10-31 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022247-001 7683051 2027-03-10 U-904 Drug substance, Drug product 2013-10-31 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022247-001 6479535 2024-05-06 U-594 Drug product 2013-10-31 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022247-001 6479535 2024-05-06 U-904 Drug product 2013-10-31 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022247-001 7683051 2027-03-10 U-594 Drug substance, Drug product 2013-10-31 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022247-001 7683051 2027-03-10 U-904 Drug substance, Drug product 2013-10-31 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022247-001 6479535 2024-05-06 U-594 Drug product 2013-10-31 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022247-001 6479535 2024-05-06 U-904 Drug product 2013-10-31 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022247-001 7683051 2027-03-10 U-594 Drug substance, Drug product 2013-10-31 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022247-001 7683051 2027-03-10 U-904 Drug substance, Drug product 2013-10-31 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022247-001 6479535 2024-05-06 U-594 Drug product 2013-10-31 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022247-001 6479535 2024-05-06 U-904 Drug product 2013-10-31 79d66fd596c7…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Duavee Active Ingredients# Ingredient, Strength table Ingredient Strength ESTROGENS, CONJUGATED .45 mg/1 BAZEDOXIFENE ACETATE 20 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination IU5QR144QX Internal UNII lookup J70472UD3D Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1441392 Internal RxNorm lookup 1441740 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 63539-122-07 Duavee 1 in 1 CARTON TABLET, FILM COATED 1 12 63539-122-07 Duavee 7 in 1 BLISTER PACK TABLET, FILM COATED 7 12
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded BAZEDOXIFENE ACETATE ACTIVE INGREDIENT J70472UD3D DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS] 2 ESTROGENS, CONJUGATED ACTIVE INGREDIENT IU5QR144QX DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS] 2 BAZEDOXIFENE ACTIVE MOIETY Q16TT9C5BK DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS] 2 ESTROGENS, CONJUGATED ACTIVE MOIETY IU5QR144QX DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS] 2 ASCORBIC ACID INACTIVE INGREDIENT PQ6CK8PD0R DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS] 2 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS] 2 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS] 2 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS] 2 FERROSOFERRIC OXIDE INACTIVE INGREDIENT XM0M87F357 DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS] 2 HYDROXYETHYL CELLULOSE (100 MPA.S AT 2%) INACTIVE INGREDIENT R33S7TK2EP DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS] 2 HYDROXYPROPYL CELLULOSE (TYPE H) INACTIVE INGREDIENT RFW2ET671P DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS] 2 HYPROMELLOSE 2208 (100000 MPA.S) INACTIVE INGREDIENT VM7F0B23ZI DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS] 2 ISOPROPYL ALCOHOL INACTIVE INGREDIENT ND2M416302 DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS] 2 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS] 2 MALTITOL INACTIVE INGREDIENT D65DG142WK DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS] 2 POLOXAMER 188 INACTIVE INGREDIENT LQA7B6G8JG DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS] 2 POLYDEXTROSE INACTIVE INGREDIENT VH2XOU12IE DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS] 2 POLYETHYLENE GLYCOL 400 INACTIVE INGREDIENT B697894SGQ DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS] 2 POVIDONES INACTIVE INGREDIENT FZ989GH94E DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS] 2 POWDERED CELLULOSE INACTIVE INGREDIENT SMD1X3XO9M DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS] 2 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS] 2 SUCROSE INACTIVE INGREDIENT C151H8M554 DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS] 2 SUCROSE PALMITATE INACTIVE INGREDIENT 3OSQ643ZK5 DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS] 2 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS] 2 TRIBASIC CALCIUM PHOSPHATE INACTIVE INGREDIENT 91D9GV0Z28 DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS] 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 63539-122 DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS] 10 Current NDC, Legacy NDC, 2 package rows 20250112_e16705d8-4472-4f83-96ac-69fa2be066cb.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Duavee CONJUGATED ESTROGENS/BAZEDOXIFENE U.S. Pharmaceuticals e16705d8-4472-4f83-96ac-69fa2be066cb 2026-07-31 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 022247 application number: NDA022247 ndc (product): 63539-122 Duavee CONJUGATED ESTROGENS/BAZEDOXIFENE Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. e1b75458-2e5b-46b9-92c6-fa6daba3770f 2026-04-28 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 022247 application number: NDA022247
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 63539-122-07 63539012207 1 BLISTER PACK in 1 CARTON (63539-122-07) / 7 TABLET, FILM COATED in 1 BLISTER PACK 1 blister pack 2013-11-15 2026-12-31 Yes No Current